Our services

Clinical development strategy and study design guidance

Armstrong Clinical provides clinical development strategy and study design guidance to biopharmaceutical companies and medical research institutes.

We add value across the clinical development lifecycle from Phase I studies through to Phase IV with sound regulatory insights, design options, gated target planning, study complexity, implementation and location advice.

Specialists at Armstrong Clinical work with you to tailor your clinical studies and development programs, decrease risk and meet regulatory, developmental, commercial, budget and time objectives.